Workflow
Jones Soda Sets First Quarter 2025 Conference Call for Thursday, May 15, 2025, at 4:30 p.m. ET
GlobeNewswire· 2025-05-12 20:30
SEATTLE, May 12, 2025 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced it will hold a conference call on Thursday, May 15, 2025, at 4:30 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2025. The financial results will be reported in a press release prior to the conference call. Chief Executive Officer Scott Harvey and Chief Financial Officer Brian Meadows will host the conference call, follow ...
Fuel Tech Reports 2025 First Quarter Financial Results
GlobeNewswire News Room· 2025-05-12 20:30
Select First Quarter 2025 Highlights Revenue rose 29% to $6.4 millionGross margin expanded to 46.4%Operating loss narrowed to $1.0 millionBacklog rose 66% to $10.3 millionCash, cash equivalents and investments of $31.2 million, no long-term debt WARRENVILLE, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Fuel Tech, Inc. (NASDAQ: FTEK), a technology company using advanced engineering processes to provide emissions control systems and water treatment technologies in utility and industrial applications, today reported ...
Vireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger Transactions
GlobeNewswire· 2025-05-12 20:30
– Acquisitions strengthen profitability and competitive position with proprietary technology platform – – Missouri and Nevada transactions remain on track to close during the second quarter of 2025 – MINNEAPOLIS, May 12, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it has closed its previously-announced transactions to acquire Utah-based WholesomeCo Cannabis (“Wholesome”) and the Arches proprietary technology and analytics platform. Wh ...
Stran & Company Schedules First Quarter 2025 Financial Results and Business Update Conference Call
GlobeNewswire· 2025-05-12 20:30
Quincy, MA, May 12, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ: SWAG) (NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced it will host a conference call at 10:00 A.M. Eastern Time on Friday, May 16, 2025, to discuss the Company’s financial results for the first quarter of 2025 ended March 31, 2025, as well as the Company’s corporate progress and other developments. T ...
Altus Group Announces Q2 2025 Dividend Payment
GlobeNewswire· 2025-05-12 20:30
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today that its Board of Directors approved the payment of a cash dividend of $0.15 per common share for the second quarter ending June 30, 2025. Payment will be made on July 15, 2025 to common shareholders of record as at June 30, 2025. Altus Group’s Dividend Reinvestment Plan (“DRIP”) permits eligible shareholders to direct t ...
Tandy Leather Factory Reports First Quarter 2025 Results
GlobeNewswire· 2025-05-12 20:30
FORT WORTH, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Tandy Leather Factory, Inc. (Nasdaq: TLF) today announced the Company’s financial results for the first fiscal quarter of 2025. Highlights from first quarter 2025: Revenues were $19.0 million, down 1.2% from 2024Generated operating income of $0.3 millionNet income from operations of $0.3 million, down from $0.7 million in 2024Gross margins of 56.3%, down from 56.7% in 2024Operating expenses $10.5 million, up 1.8% from 2024Adjusted net income of $0.4 millio ...
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire· 2025-05-12 20:30
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1 study of TNX-1500, a next generation anti-CD40L mAb candidate in development for prevention of kidney transplant rejection and treatment of autoimmune disorders Cash and cash equivalents of $131.7 million reported as of March 31, 2025; Current cash sufficient to fund o ...
Carbon Revolution Sets Date for Fiscal 2024 Earnings Release and Conference Call
GlobeNewswire· 2025-05-12 20:30
GEELONG, Australia, May 12, 2025 (GLOBE NEWSWIRE) -- Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 automotive supplier and the world’s leading manufacturer of innovative, lightweight carbon fiber wheels, announced today it will hold a conference call to discuss its fiscal 2024 results on May 15, 2025 at 8:00 A.M Eastern time. After market close on May 14, the Company will issue a copy of the earnings press release via Globe Newswire. The press release may also be viewed on the News section ...
NIP Group Inc. Filed 2024 Annual Report on Form 20-F
GlobeNewswire News Room· 2025-05-12 20:30
ABU DHABI, United Arab Emirates, May 12, 2025 (GLOBE NEWSWIRE) -- NIP Group Inc. (“NIPG” or the “Company”) (NASDAQ: NIPG), a leading digital entertainment company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission (the "SEC") on May 12, 2025. The annual report, which contains the Company’s audited consolidated financial statements, can be accessed on the Company's investor relations website at ir.nipgroup. ...
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire· 2025-05-12 20:30
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapySEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in mechanism targeted cancer indication-Ewing Sarcoma, remains on track for IND filing mid‑2025 FLORHAM PARK, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical‑stage global biopharmaceutical company focused on developing cancer ...